Cytosine deaminase versus thymidine kinase: A comparison of the antitumor activity

Clinical and Experimental Medicine

Volumn 3, Issue 3, 2003, Pages 150-156

  Corban Wilhelm, H ^a   Becker, G ^a   Bauder Wust U ^a   Greulich, D ^a   Debus, J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

5 Fluorocytosine; Cytosine deaminase; Ganciclovir; Gene therapy; Thymidine kinase

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL ENZYME; CYTOSINE DEAMINASE; FLUCYTOSINE; GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FUSION GENE; GENE ACTIVATION; GENETIC TRANSFECTION; IN VIVO STUDY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; STATISTICAL SIGNIFICANCE; SUICIDE GENE THERAPY; SURVIVAL; TUMOR CELL LINE; TUMOR RECURRENCE; WILD TYPE;

ANIMALS; ANTIVIRAL AGENTS; CYTOSINE DEAMINASE; ESCHERICHIA COLI; FLUOROURACIL; GANCICLOVIR; GENE THERAPY; HERPESVIRUS 1, HUMAN; MALE; PROSTATIC NEOPLASMS; RATS; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SIMPLEXVIRUS;

EID: 0345376156     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-003-0018-8     Document Type: Article

References (25)

1. Arner ES, Eriksson S (1995) Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67:155-186
2. Faulds D and Heel RC (1990) Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 39:597-638
3. Moolten FL (1994) Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther 1:279-287
4. Danielsen S, Kilstrup M, Barilla K, Jochimsen B, Neuhard J (1992) Characterization of the Escherichia coli codBA operon encoding cytosine permease and cytosine deaminase. Mol Microbiol 6:1335-1344
5. Heidelberger C, Chaudhuri NK, Danneberg P, Mooren D, Griesbach L, Duschinsky R, Schnitzer RJ, Pleven E, Scheiner J (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179:663-666
6. Weckbecker G (1991) Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators. Pharmacol Ther 50:367-424
7. Nishiyama T, Kawamura Y, Kawamoto K, Matsumura H, Yamamoto N, Ito T, Ohyama A, Katsuragi T, Sakai T (1985) Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 45:1753-1761
8. Wallace PM, MacMaster JF, Smith VF, Kerr DE, Senter PD and Cosand WL (1994) Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res 54:2719-2723
9. Daher GC, Harris BE and Diasio RB (1990) Metabolism of pyrimidine analogues and their nucleosides. Pharmacol Ther 48:189-222
10. Rogulski KR, Kim JH, Kim SH and Freytag SO (1997) Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. Hum Gene Ther 8:73-85
11. Ferraro C, Quemeneur L, Prigent AF, Taverne C, Revillard JP, Bonnefoy-Berard N (2000) Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res 60:1901-1907
12. Rogulski KR, Zhang K, Kolozsvary A, Kim JH, Freytag SO (1997) Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res 3:2081-2088
13. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE (1995) Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 55:4808-4812
14. Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, Liu T, Curiel DT (1996) Approaches to enhance cancer radiotherapy employing gene transfer methods. Gene Ther 3:1042-1068
15. Kuriyama S, Mitoro A, Yamazaki M, Tsujinoue H, Nakatani T, Akahane T, Toyokawa Y, Kojima H, Okamoto S, Fukui H (1999) Comparison of gene therapy with the herpes simplex virus thymidine kinase gene and the bacterial cytosine deaminase gene for the treatment of hepatocellular carcinoma. Scand J Gastroenterol 34:1033-1041
16. Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase, Biochim Biophys Acta 1587:164-173
17. Springer CJ, Niculescu D, I (2000) Prodrug-activating systems in suicide gene therapy. J Clin Invest 105:1161-1167
18. Consalvo M, Mullen CA, Modesti A, Musiani P, Allione A, Cavallo F, Giovarelli M, Forni G (1995) 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol 154:5302-5312
19. Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297-300
20. Uckert W, Kammertons T, Haack K, Qin Z, Gebert J, Schendel DJ, Blankenstein T (1998) Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo. Hum Gene Ther 9:855-865
21. Freytag SO, Khil M, Stricker H, Peabody J, Menon M, DePeralta-Venturina M, Nafziger D, Pegg J, Paielli D, Brown S, Barton K, Lu M, Aguilar-Cordova E, Kim JH (2002) Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Cancer Res. 62:4968-4976
22. Byfield JE (1989) 5-Fluorouracil radiation sensitization - a brief review. Invest New Drugs 7:111-116
23. Lawrence TS, Davis MA, J.Maybaum J (1994) Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects. Int J Radiat Oncol Biol Phys 29:519-523
24. Corban-Wilhelm H, Hull WE, Becker G, Bauder-Wust U, Greulich D and Debus J (2002) Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with (19)F-NMR spectroscopy. Gene Ther 9:1564-1575
25. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg RG, Tjuvajev JG, Ross BD (1999) Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 96:9821-9826